Table 5.
CYP2B6 | FMO5 | NAT1 | SULT2B1 | GSTM3 | ABCC11 | ESR1/ERα | |
CYP2A6 | + 0.471 [< 0.001] | + 0.171 [NS (0.091)] | + 0.248 [0.014] | + 0.084 [NS (0.42)] | -0.037 [NS (0.72)] | -0.173 [NS (0.086)] | + 0.281 [0.0053] |
CYP2B6 | + 0.525 [< 0.001] | + 0.433 [< 0.001] | + 0.083 [NS (0.42)] | + 0.022 [NS (0.83)] | + 0.022 [NS (0.82)] | + 0.409 [< 0.001] | |
FMO5 | + 0.420 [< 0.001] | -0.099 [NS (0.34)] | -0.008 [NS (0.93)] | + 0.216 [0.032] | + 0.316 [0.0018] | ||
NAT1 | + 0.077 [NS (0.46)] | + 0.104 [NS (0.31)] | + 0.041 [NS (0.69)] | + 0.293 [0.0037] | |||
SULT2B1 | + 0.232 [0.021] | + 0.049 [NS (0.64)] | + 0.091 [NS (0.38)] | ||||
GSTM3 | + 0.198 [0.049] | + 0.239 [0.018] | |||||
ABCC11 | + 0.023 [NS (0.82)] |
Data presented as Spearman rank correlation coefficient [P value (Spearman rank correlation test)]. NS, not significant.